@article {46609,
	title = {Role of cysteines in accelerating Tau filament formation},
	journal = {Journal of Biomolecular Structure \& Dynamics},
	volume = {40},
	year = {2022},
	month = {JUN},
	pages = {4366-4375},
	type = {Article},
	abstract = {<p>
	Alzheimer{\textquoteright}s disease is majorly associated with intracellular accumulation of Tau into paired helical filaments and tangles. The self-aggregated dimeric and oligomeric species of Tau formed are more toxic to neuronal cells and acts as seeds for filament formation. The two cysteine residues and the two hexapeptide regions of full-length Tau play a key role in initialization and filament formation during Tau aggregation. The role of cysteine residues in Tau aggregation has been studied by in-vitro aggregation assay that was measured by Thioflavin S fluorescence to observe the kinetics of aggregation. In this study, we have performed in-vitro aggregation assay with recombinant full-length Tau and the cysteine mutants to understand the mechanism of cysteine independent Tau aggregation. Here, we report that cysteine mutant full-length Tau can aggregate to form filaments under in-vitro conditions. To visualize the polymorphisms of Tau and cysteine mutants under different aggregation conditions anionic cofactor, heparin was employed. Wild-type Tau showed rapid aggregation to form oligomers and filaments. On the other hand, the cysteine mutant delayed the initial Tau aggregation. This indicates the importance of cysteine residues in accelerating initial Tau nucleation for its aggregation. The filament morphology of wild-type and cysteine mutant Tau has been characterized using transmission electron microscopy and high-resolution transmission electron microscopy. Communicated by Ramaswamy H. Sarma</p>
},
	keywords = {Heparin-induced aggregation, Paired helical filaments, Tau Aggregation, Tau Oligomers, tau protein},
	issn = {0739-1102},
	doi = {10.1080/07391102.2020.1856720},
	author = {Chidambaram, Hariharakrishnan and Chinnathambi, Subashchandrabose}
}
